Insight Wealth Strategies’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-20,295
Closed -$1.67M – 176
2023
Q4
$1.67M Buy
20,295
+1,704
+9% +$130K 0.27% 92
2023
Q3
$1.46M Buy
18,591
+1,972
+12% +$165K 0.28% 79
2023
Q2
$1.46M Buy
16,619
+452
+3% +$38.9K 0.28% 71
2023
Q1
$1.3M Buy
16,167
+1,700
+12% +$139K 0.26% 75
2022
Q4
$1.12M Buy
14,467
+712
+5% +$57.7K 0.22% 83
2022
Q3
$1.24M Hold
13,755
– – 0.23% 82
2022
Q2
$1.24M Buy
+13,755
New +$1.39M 0.23% 82
2019
Q1
– Sell
-4,642
Closed -$422K – 145
2018
Q4
$422K Buy
+4,642
New +$434K 0.13% 96

Other funds holding MDT

Insight Wealth Strategies's MDT Position: Q1 2024 in Review

Insight Wealth Strategies sold out of Medtronic (MDT) in Q1 2024, closing a stake of 20,295 shares — an estimated $1.67M sold.

Insight Wealth Strategies first reported a position in MDT in Q4 2018 and held it in 8 quarters. The position peaked at $1.67M in Q4 2023. 2,081 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Insight Wealth Strategies reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Insight Wealth Strategies sold 20,295 Medtronic shares in Q1 2024, an estimated $1.67M.
  • Insight Wealth Strategies first reported a position in Medtronic in Q4 2018 and held it in 8 quarters.
  • Insight Wealth Strategies's Medtronic position peaked at $1.67M in Q4 2023.
  • 2,081 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Insight Wealth Strategies's 13F filing for Q1 2024, filed 5 Apr 2024.